MITCHELL CLAIRE: Open Payments
NPI 1881611317 · COACHELLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 16 payments from 5 companies in 2025. Trend: 2023 $406 · 2024 $563 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $248 |
| GlaxoSmithKline, LLC. | 4 | $106 |
| Alkermes, Inc. | 1 | $98 |
| Ionis Pharmaceuticals, Inc. | 3 | $76 |
| Smith+Nephew, Inc. | 1 | $38 |
Products named: DUPIXENT, NUCALA, VIVITROL, DAWNZERA, TULA.
Industry payments across CA — which companies pay providers there.
